If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Software Group Regulatory News (APTD)

Share Price Information for Aptitude Software Group (APTD)

Share Price is delayed by 15 minutes
Get Live Data
203.00    0.00 (0.00%)
Bid:
199.00
Ask:
203.00
Spread: 4.00 (2.01%)
Market Cap: £108.65m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Software Group Share Chart

Interim Management Statement and Special Dividend

1 Nov 2011 07:00

RNS Number : 2017R
Microgen PLC
01 November 2011
 



microgen

www.microgen.com

 

1 November 2011

 

INTERIM MANAGEMENT STATEMENT AND SPECIAL DIVIDEND

 

Microgen plc ('Microgen' or 'the Group') provides its Interim Management Statement covering the period from 1 July 2011 to the date of this announcement. Microgen released its interim results for the six months ending 30 June 2011 on 21 July 2011.

 

There have been no significant changes since 1 July 2011 in the trading or financial position of Microgen and its balance sheet remains strong. In September, Microgen repaid the £1.6 million loan associated with its Fleet freehold property, after which the Group had cash at 30 September 2011 of £26.0 million (Net Funds at 30 June 2011 : £25.2 million).

 

Since 1 July 2011 the Microgen Aptitude Solutions Division ("MASD") has further expanded its customer base and the Financial Systems Division ("FSD") continues to perform satisfactorily in a flat market environment. Due in part to the consultancy demand on a number of projects in 2011, the Group's performance is now anticipated to be moderately ahead of the Board's expectations for the year, although the Board remains cautious due to the current macro-economic environment.

 

As a result of the strong financial position of Microgen, the Board has decided to pay a special dividend of 5.0 pence per share. The special dividend will be paid on 9 December 2011 to shareholders on the register as at 11 November 2011.

 

Three years ago, in October 2008, the Board introduced the Value Enhancement and Realisation Bonus Scheme ("VERBS"), at which time the market capitalisation of Microgen was £37.0 million. Including the forthcoming special dividend the Board has, since the introduction of VERBS, returned £28.2 million to shareholders through a progressive dividend policy, special dividends and tender offers. This is equivalent to over 75% of the Group's market capitalisation at the time of the introduction of VERBS. Furthermore, Microgen's market capitalisation, at 31 October 2011, has increased to £122.9 million.

 

 

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

David Sherriff, Chief Executive Officer

Philip Wood, Group Finance Director

 

James Melville-Ross, FTI Consulting 020-7831-3113

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUAABRAOAROAA
Date   Source Headline
29th Sep 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Sep 20232:28 pmRNSHolding(s) in Company
20th Sep 20239:32 amRNSHolding(s) in Company
7th Sep 202310:15 amRNSGrant of Awards under Performance Share Plan
23rd Aug 20231:21 pmRNSHolding(s) in Company
23rd Aug 20231:15 pmRNSHolding(s) in Company
28th Jul 202312:18 pmRNSHolding(s) in Company
28th Jul 20237:00 amRNSHolding(s) in Company
27th Jul 20231:52 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSInterim Results
24th Jul 20235:22 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSHolding(s) in Company
19th Jul 20237:00 amRNSDirector Retirement
13th Jul 20237:00 amRNSTrading Update and Directorate Changes
23rd Jun 20234:43 pmRNSHolding(s) in Company
16th Jun 20234:22 pmRNSHolding(s) in Company
25th May 20235:22 pmRNSDirector/PDMR Shareholding
24th May 202311:01 amRNSHolding(s) in Company
23rd May 20236:10 pmRNSDirector/PDMR Shareholding
23rd May 20233:27 pmRNSHolding(s) in Company
17th May 202311:24 amRNSResult of AGM
17th May 20237:00 amRNSAGM Statement and Appointment of CFO
2nd May 202311:44 amRNSHolding(s) in Company
24th Apr 20235:13 pmRNSExercise of awards under 2020 Deferred Bonus Plan
20th Apr 202311:30 amRNSGrant of awards under 2020 Deferred Bonus Plan
17th Apr 202311:49 amRNSHolding(s) in Company
17th Apr 20238:32 amRNSHolding(s) in Company
29th Mar 20234:36 pmRNSDirector/PDMR Shareholding
29th Mar 20234:35 pmRNSPrice Monitoring Extension
29th Mar 202311:27 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Mar 20237:00 amRNSAudited Results for Year Ended 31 December 2022
13th Feb 20235:20 pmRNSHolding(s) in Company
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSHolding(s) in Company
24th Jan 20237:00 amRNSFull Year Trading Update and Directorate Change
12th Jan 20239:51 amRNSNew Directorship Notification
24th Nov 20227:00 amRNSGrant of awards under Performance Share Plan
8th Nov 20227:00 amRNSGrant of awards
21st Oct 20224:41 pmRNSSecond Price Monitoring Extn
21st Oct 20224:36 pmRNSPrice Monitoring Extension
28th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
28th Jul 20227:00 amRNSInterim Results
18th Jul 20227:00 amRNSNotice of Results
31st May 202211:40 amRNSTotal Voting Rights
26th May 20228:56 amRNSHolding(s) in Company
17th May 20221:57 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20222:10 pmRNSDirector Shareholding
29th Apr 202210:56 amRNSTotal Voting Rights
28th Apr 202212:24 pmRNSResult of AGM and Directorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.